Purpose of Study: This clinical trial is studying quality of life in female breast cancer survivors and their spouse, partner or acquaintance.

Objectives:

• Compare the quality of life (physical functioning, psychological functioning, social functioning, and spiritual functioning) of female breast cancer survivors who were age 45 or younger at the time of diagnosis with the quality of life of female breast cancer survivors who were age 55 to 70 at time of diagnosis (considering type of surgical treatment [lumpectomy vs mastectomy], hormonal treatments, and time since diagnosis as covariates) and age-matched (to the younger group) females with no history of breast cancer.
• Compare the quality of life (physical functioning, psychological functioning, social functioning, and spiritual functioning) of partners of breast cancer survivors who were age 45 or younger at time of diagnosis with the quality of life of partners of breast cancer survivors who were age 55 to 70 at diagnosis and partners of age-matched (to the younger group) females with no history of breast cancer.

Elgibility: Ages Eligible for Study: 18 Years - 78 Years, Genders Eligible for Study: Female

Criteria:

Disease Characteristics:

Patient: Female breast cancer survivor with age at initial diagnosis in 1 of the following ranges: 18-45 or 55-78 
 Must have enrolled and participated in ECOG study CLB-9741, E-1199, or E-2197 
 Must have received chemotherapy at least 3 years, but no more than 8 years prior to this study entry 
 Disease free at the time of this study entry

Spouse or partner of the patient, age-matched female acquaintances of the patient (in the younger patient group), or partner of acquaintances:

 Spouse or partner of the patient may be either gender 
 Age-matched female acquaintance is defined as within 5 years of age difference of the patient in younger group (18-45 years of age) 
 With a similar level of education and race of the patient 
 Not a personal friend of the patient 
 No history of breast cancer

Paitent Characteristics:

Must reside in the continental U.S. and speak English (for patients)

Contact: http://clinicaltrials.gov/ct/show/NCT00309933;jsessionid=BC0784910346DF97E34FBF35CC8F8EB8?order=41